510(k) Report

510(k) · Cleared

Cleared

Embo Plus Embolectomy Catheter

K100840510(k) TraditionalCleared Jul 12, 2010110-day reviewClass II21 CFR 870.5150

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Hotspur Technologies · DXE Catheter, Embolectomy

Cleared on Jul 12, 2010 as substantially equivalent to K892410 (Baxter Healthcare Corp, 1989) after a 110-day review. Its family tree reaches back 1 generation to 1989.

Decided
Jul 12, 2010
Review
110 days
Class
Class II
Product code
DXE
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K892410 (1989). No later device cites it as a predicate yet.

K892410 · Fogarty (R) Thru-Lumen Embolectomy Catheter · Baxter Healthcare Corp · 1989 · recalled198519901995200020052010
  1. Root · 1 generation backK892410 Fogarty (R) Thru-Lumen Embolectomy CatheterBaxter Healthcare Corp · 1989 · Recalled
  2. This deviceK100840 Embo Plus Embolectomy CatheterHotspur Technologies · 2010
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K892410Fogarty (R) Thru-Lumen Embolectomy CatheterBaxter Healthcare Corp19891
0 (this device)K100840Embo Plus Embolectomy CatheterHotspur Technologies2010—
FIG. 1 — Lineage of K100840, 1989–2010Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DXE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DXE device

  1. #1 K240078 Fogarty Thru-Lumen Embolectomy Catheterscore 7.9 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K892410Fogarty (R) Thru-Lumen Embolectomy Catheter
Summary page 1
…olectomy (21 CFR 870.5150, Product Code DXE) C. Predicate Device Name(s) Trade Name(s): Fogarty Thin-Lumen Embolectomy Catheter, K892410 D. Device Description: The proposed EMBO-Plus Embolectomy Catheter is designed for the removal of fresh, soft embol…
Baxter Healthcare Corp19891

Also cleared against K892410: 5 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.
  • 5 other devices also cite its predicate K892410.

How does its category compare?

All DXE devices

DXE Catheter, Embolectomy: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · DXE

5in 2024

2008: 12010: 22015: 12017: 22020: 12021: 12022: 12024: 5
2007high 5 (2024) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DXE

173in 2024

2024: 173 days median
2007high 173 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DXE

1in 2023

2007: 32009: 52010: 12011: 12015: 132021: 4, 4 Class I2022: 32023: 12026 (partial year): 2
2007high 13 (2015) · low 0 (2008)2026

Class I (4 since 2007) Class II/III not classified

Adverse event reports per year · DXE

306in 2025

2007: 1672008: 1342009: 1242010: 1362011: 1642012: 2002013: 1502014: 1922015: 2662016: 7962017: 7702018: 6152019: 5942020: 5472021: 3332022: 4632023: 4362024: 3772025: 306
2007high 796 (2016) · low 124 (2009)2025

MAUDE reports naming product code DXE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—3167
20081—0134
20090—5124
20102—1136
20110—1164
20120—0200
20130—0150
20140—0192
20151—13266
20160—0796
20172—0770
20180—0615
20190—0594
20201—0547
20211—4 (4)333
20221—3463
20230—1436
202451730377
20250—0306
20260—2—

What is it indicated for?

The EMBO-Plus Embolectomy Catheter is indicated for use within vessels in the arterial system and synthetic arteriovenous dialysis fistulae for the removal of fresh, soft emboli and thrombi.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K100840: Embo Plus Embolectomy Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K100840

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026